Life Sciences
Pronostics has high hopes for German diagnostics distribution deal | Pronostics has high hopes for German diagnostics distribution deal |
| Written by Ben Fountain | |
| Wednesday, 12 March 2008 | |
|
Cambridge diagnostics company, Pronostics has signed a distribution agreement with German company, Medipan for technology that allows doctors to diagnose autoimmune diseases. Medipan will sell Pronostics’ UltraPlex ANA, Coeliac and Thyroid assays in Germany and Austria. Germany is Europe’s largest market for diagnostic products. As part of the agreement, Medipan will market the assays to hospitals and large private laboratories. Pronostics says the deal could initially generate up to £1.53m (€2m) in revenues. Medipan will have an exclusive license to sell Pronostics' UltraPlex assays throughout the territory. The 2005 worldwide market for autoimmune tests was estimated at $250M and forecast to grow to $410M by 2010, according to research from Kalorama Information. Robert Booth, CEO of Pronostics said: "The agreement is an endorsement of the superiority of our UltraPlex technology which underpins our range of multiplexed diagnostic assays. With this agreement, we can now expand the benefits of UltraPlex into the largest market for diagnostics in Europe." UltraPlex is a digital multiplexing system which enables tens to hundreds of tests to be performed simultaneously in a single assay using a microscopic bar-coding system. The company’s lead product, the UltraPlex ANA assay, which consists of 11 tests in one, provides time and cost savings compared to existing serial testing approaches, according to Pronostics. Dr Dirk Roggenbuck, CEO from Medipan, added: “The UltraPlex platform is more efficient and economical in the diagnosis of autoimmune diseases than conventional approaches and we are looking forward to providing our customers with this improved service.”
Set as favorite
Bookmark
Email This
Hits: 432 Trackback(0)
Comments (0)
![]() Write comment
This content has been locked. You can no longer post any comment.
|
| < Prev | Next > |
|---|
![]() Blue Lizard Marketing www.bluelizardmarketing.com Category: Marketing and PR |